AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16432076 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose therapy (HDT) with melphalan 140 mg/m2 plus total-body irradiation 12 Gy
Number of subjects: 516
Study 16432076 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose therapy (SDT) using vincristine, carmustine, melphalan, cyclophosphamide, and prednisone
Number of subjects: 516
Study 16432076 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose therapy (HDT)
Number of subjects: 516
Study 16432076 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose therapy (SDT)
Number of subjects: 516
Study 16432076 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon (IFN) maintenance therapy
Number of subjects: 516
Study 16432076 — intervention group
Group type: COMPARATOR
Intervention: No maintenance therapy
Number of subjects: 516
Study 16432076 — intervention group
Group type: EXPERIMENTAL
Intervention: Salvage autotransplantation after relapse on SDT
Number of subjects: 516
Study 16432076 — intervention group
Group type: COMPARATOR
Intervention: Further standard-dose therapy (SDT) after relapse
Number of subjects: 516
Study 15224704 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids (group S)
Number of subjects: 110
Study 15224704 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole (group A)
Number of subjects: 110
Study 15224704 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids and Albendazole (group SA)
Number of subjects: 110
Study 11513193 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant interleukin-12 (rhIL-12) at a dose of 300 ng/kg
Number of subjects: 24
Study 11513193 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 9640077 — intervention group
Group type: EXPERIMENTAL
Intervention: IDDM with albuminuria
Number of subjects: 34
Study 9640077 — intervention group
Group type: COMPARATOR
Intervention: IDDM without microalbuminuria
Number of subjects: 34
Study 9640077 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 34
Study 8489988 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 1% plus epinephrine at 650 mg
Number of subjects: 45
Study 8489988 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine 1% plus epinephrine at 500 mg
Number of subjects: 45
Study 3488982 — intervention group
Group type: EXPERIMENTAL
Intervention: External electrostimulation (EES)
Number of subjects: 0
Study 3488982 — intervention group
Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 0
Study 29450877 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative paracetamol (IV infusion of paracetamol 15 mg kg‐1 1 h before surgery)
Number of subjects: 96
Study 29450877 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative paracetamol (IV infusion of paracetamol 15 mg kg‐1 in recovery room)
Number of subjects: 96
Study 29450877 — intervention group
Group type: COMPARATOR
Intervention: Control (IV infusion of saline pre‐ and postoperatively)
Number of subjects: 96
Study 26948991 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure lowering (target SBP < 140 mmHg)
Number of subjects: 2623
Study 26948991 — intervention group
Group type: COMPARATOR
Intervention: Guideline-based blood pressure management (target SBP < 180 mmHg)
Number of subjects: 2623
Study 24357575 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidimensional Treatment Foster Care for Adolescents (MTFC‐A)
Number of subjects: 219
Study 24357575 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 219
Study 21899712 — intervention group
Group type: EXPERIMENTAL
Intervention: long‐course chemoradiotherapy (chRT)
Number of subjects: 83
Study 21899712 — intervention group
Group type: COMPARATOR
Intervention: short‐term radiotherapy (sRT)
Number of subjects: 83
Study 16011564 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooled filtered water with active promotion (W + P)
Number of subjects: 0
Study 16011564 — intervention group
Group type: EXPERIMENTAL
Intervention: Water only (W)
Number of subjects: 0
Study 16011564 — intervention group
Group type: COMPARATOR
Intervention: Control school (C)
Number of subjects: 0
Study 12572529 — intervention group
Group type: EXPERIMENTAL
Intervention: tolterodine L-tartrate (2 mg twice daily)
Number of subjects: 20
Study 12572529 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study 9459246 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine plus 2 mL sodium bicarbonate 8.4%
Number of subjects: 24
Study 9459246 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine hydrochloride
Number of subjects: 24
Study 9459246 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine CO2
Number of subjects: 24
Study 8590507 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 4 micrograms.kg‐1
Number of subjects: 140
Study 8590507 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study 8590507 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 0.4 mg.kg‐1
Number of subjects: 140
Study 8590507 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 2 micrograms.kg‐1
Number of subjects: 140
Study 2225951 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrrolate (2 mg every 2 hours for 6 hours)
Number of subjects: 46
Study 2225951 — intervention group
Group type: COMPARATOR
Intervention: Metaproterenol (15 mg every 2 hours for 6 hours)
Number of subjects: 46
Study 24686 — intervention group
Group type: EXPERIMENTAL
Intervention: Antacid suspensions (liquid form)
Number of subjects: 36
Study 24686 — intervention group
Group type: COMPARATOR
Intervention: Antacid chewing tablets
Number of subjects: 36
Study 29895341 — intervention group
Group type: COMPARATOR
Intervention: Ear wick (n = 28)
Number of subjects: 92
Study 29895341 — intervention group
Group type: COMPARATOR
Intervention: Ribbon gauze (n = 34)
Number of subjects: 92
Study 29895341 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodegradable synthetic polyurethane foam (n = 30)
Number of subjects: 92
Study 28266242 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (135 mg daily)
Number of subjects: 72
Study 28266242 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 24136056 — intervention group
Group type: EXPERIMENTAL
Intervention: Midline posterior approach
Number of subjects: 50
Study 24136056 — intervention group
Group type: COMPARATOR
Intervention: Paraspinal approach
Number of subjects: 50
Study 23782513 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimotuzumab
Number of subjects: 70
Study 23782513 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 21126230 — intervention group
Group type: EXPERIMENTAL
Intervention: iPod™ lectures
Number of subjects: 35
Study 21126230 — intervention group
Group type: COMPARATOR
Intervention: Classroom lectures without iPods™
Number of subjects: 35
Study 21126230 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent use of iPod™ before final exam
Number of subjects: 35
Study 17999695 — intervention group
Group type: EXPERIMENTAL
Intervention: BellyBra
Number of subjects: 115
Study 17999695 — intervention group
Group type: COMPARATOR
Intervention: tubigrip
Number of subjects: 115
Study 16476843 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine+/−perindopril-based therapy
Number of subjects: 2199
Study 16476843 — intervention group
Group type: COMPARATOR
Intervention: Atenolol+/−thiazide-based therapy
Number of subjects: 2199
Study 16476843 — intervention group
Group type: EXPERIMENTAL
Intervention: Central pulse pressure
Number of subjects: 2199
Study 12742836 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 hours of daily patching combined with at least 1 hour per day of near visual activities
Number of subjects: 189
Study 12742836 — intervention group
Group type: COMPARATOR
Intervention: 6 hours of daily patching combined with at least 1 hour per day of near visual activities
Number of subjects: 189
Study 11075250 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole
Number of subjects: 36
Study 11075250 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 36
Study 11075250 — intervention group
Group type: COMPARATOR
Intervention: No antibiotics
Number of subjects: 36
Study 8603558 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-aminosalicylic acid (5-ASA) treatment with end-to-end anastomosis
Number of subjects: 110
Study 8603558 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-aminosalicylic acid (5-ASA) treatment with side-to-side or end-to-side anastomosis
Number of subjects: 110
Study 8603558 — intervention group
Group type: COMPARATOR
Intervention: End-to-end anastomosis
Number of subjects: 110
Study 8603558 — intervention group
Group type: COMPARATOR
Intervention: No specific control intervention mentioned
Number of subjects: 110
Study 1419473 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment (1 mg perindoprilat in 30 ml) over 1 h
Number of subjects: 8
Study 1419473 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment (1 mg perindoprilat in 30 ml) over 3 h
Number of subjects: 8
Study 1419473 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment (1 mg perindoprilat in 30 ml) over 6 h
Number of subjects: 8
Study 1419473 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo (30 ml) over 3 h
Number of subjects: 8
Study 3965336 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicozamycin (500 mg four times a day for 3 weeks)
Number of subjects: 30
Study 31615577 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial online survey
Number of subjects: 456
Study 31615577 — intervention group
Group type: EXPERIMENTAL
Intervention: Interim online survey
Number of subjects: 456
Study 31615577 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face consensus meeting
Number of subjects: 456
Study 31615577 — intervention group
Group type: EXPERIMENTAL
Intervention: Top 10 questions
Number of subjects: 456
Study 29716756 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional imaging
Number of subjects: 1202
Study 26580300 — intervention group
Group type: EXPERIMENTAL
Intervention: Alex stent (second-generation cobalt-chromium sirolimus-eluting stent)
Number of subjects: 424
Study 25294214 — intervention group
Group type: EXPERIMENTAL
Intervention: Overfeeding with 140% of energy needs, with 5, 15, or 25% of energy from protein for 56 days
Number of subjects: 25
Study 25294214 — intervention group
Group type: EXPERIMENTAL
Intervention: Overfeeding with 140% of energy needs
Number of subjects: 25
Study 23227677 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at Renying (ST 9), Hegu (LI 4), Taichong (LR 3), Quchi (LI 11), and Zusanli (ST 36) for 3 months, 5 days a week with 2 days off
Number of subjects: 70
Study 20722847 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone (5 mg/d)
Number of subjects: 131
Study 20722847 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131
Study 18388249 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic cycle training (30 min at 60% of peak O2 uptake, 3 days/week for 8 weeks)
Number of subjects: 22
Study 18388249 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic cycle training
Number of subjects: 22
Study 18388249 — intervention group
Group type: COMPARATOR
Intervention: Single bout of exercise
Number of subjects: 22
Study 15970828 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release oxybutynin (10 mg/d)
Number of subjects: 790
Study 15970828 — intervention group
Group type: COMPARATOR
Intervention: Extended-release tolterodine (4 mg/d)
Number of subjects: 790
Study 12452243 — intervention group
Group type: COMPARATOR
Intervention: Intravenous morphine 10 mg
Number of subjects: 88
Study 12452243 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous morphine 10 mg and lornoxicam 16 mg
Number of subjects: 88
Study 12452243 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous morphine 10 mg, lornoxicam 16 mg with 0.5% ropivacaine local skin infiltration before skin incision and 1% ropivacaine instillation before peritoneal incision
Number of subjects: 88
Study 12452243 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous morphine 10 mg, lornoxicam 16 mg with 1% ropivacaine instillation after peritoneal closure and 0.5% ropivacaine local skin infiltration before skin closure
Number of subjects: 88
Study 11563411 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard regimen (5 days high dose 1,050 mg/m2/day followed by 14 days low dose 700 mg/m2/day)
Number of subjects: 11
Study 11563411 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternate regimen (two courses of high dose therapy separated by one week)
Number of subjects: 11
Study 7580706 — intervention group
Group type: EXPERIMENTAL
Intervention: Low lipid standardised plasma vitamin E concentration (below median)
Number of subjects: 944
Study 7580706 — intervention group
Group type: EXPERIMENTAL
Intervention: Decrement of 1 mumol/l of uncategorised unstandardised vitamin E concentration
Number of subjects: 944
Study 2068533 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotically induced emotional states (anger, depression, happiness)
Number of subjects: 11
Study 2068533 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotically induced emotional states (happiness)
Number of subjects: 11
Study 2068533 — intervention group
Group type: COMPARATOR
Intervention: Before hypnosis
Number of subjects: 11
Study 2068533 — intervention group
Group type: EXPERIMENTAL
Intervention: Angry emotional state
Number of subjects: 11
Study 2068533 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressed emotional state
Number of subjects: 11
Study 2068533 — intervention group
Group type: EXPERIMENTAL
Intervention: DOPA levels
Number of subjects: 11
Study 2068533 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol levels and catecholamine plasma levels
Number of subjects: 11
Study 2068533 — intervention group
Group type: EXPERIMENTAL
Intervention: Soluble interleukin-2 receptors
Number of subjects: 11
Study 6117379 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxprenolol SR (160-320 mg/day)
Number of subjects: 6
Study 6117379 — intervention group
Group type: COMPARATOR
Intervention: Placebo (identical tablets)
Number of subjects: 6
Study 6117379 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxprenolol SR
Number of subjects: 6
Study 31706662 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid changes in temperature (large decrease)
Number of subjects: 20558
Study 31706662 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in atmospheric pressure
Number of subjects: 20558
Study 31706662 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in relative humidity
Number of subjects: 20558
Study 30452653 — intervention group
Group type: EXPERIMENTAL
Intervention: Prime (cooked to medium-rare and lower)
Number of subjects: 5
Study 30452653 — intervention group
Group type: EXPERIMENTAL
Intervention: Prime (cooked to medium and higher)
Number of subjects: 5
Study 30452653 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined cooked moisture and fat percentages
Number of subjects: 5
Study 30452653 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased marbling levels
Number of subjects: 5
Study 30452653 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooked residual moisture and fat percentages (combined)
Number of subjects: 5
Study 27417906 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined speech and gesture condition
Number of subjects: 11
Study 27417906 — intervention group
Group type: COMPARATOR
Intervention: Gesture-only condition
Number of subjects: 11
Study 27417906 — intervention group
Group type: COMPARATOR
Intervention: Speech-only condition
Number of subjects: 11
Study 25425704 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory care bundle implemented through NIC/Q 2005
Number of subjects: 1050
Study 24227733 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory-evoked activity to pure tones of high, medium, and low frequencies in anophthalmic participants
Number of subjects: 0
Study 24227733 — intervention group
Group type: COMPARATOR
Intervention: Auditory-evoked activity to pure tones of high, medium, and low frequencies in sighted controls
Number of subjects: 0
Study 21366949 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy
Number of subjects: 80
Study 21366949 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 80
Study 20039525 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based stigma education program (informative e-mail about stigma)
Number of subjects: 205
Study 20039525 — intervention group
Group type: COMPARATOR
Intervention: Control group (no informative e-mail)
Number of subjects: 205
Study 17267931 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased support through six weekly visits by a trained advisor
Number of subjects: 271
Study 17267931 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 271
Study 15521874 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-hour rest post-embryo transfer
Number of subjects: 0
Study 15521874 — intervention group
Group type: COMPARATOR
Intervention: 24-hour rest post-embryo transfer
Number of subjects: 0
Study 11885112 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-generation anticonvulsants (felbamate, gabapentin, lamotrigine, levetiracetam, oxcarbazepine, tiagabine, topiramate, zonisamide)
Number of subjects: 0
Study 11885112 — intervention group
Group type: COMPARATOR
Intervention: First-generation anticonvulsants (phenobarbital, phenytoin, valproate)
Number of subjects: 0
Study 9679794 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-mediated cholesterol management (NURS)
Number of subjects: 156
Study 9679794 — intervention group
Group type: COMPARATOR
Intervention: Enhanced primary care (EPC)
Number of subjects: 156
Study 7983283 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-discharge geriatric home assessment by a gerontologic nurse practitioner (GNP)
Number of subjects: 152
Study 7983283 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-discharge geriatric home assessment by a GNP
Number of subjects: 152
Study 2962925 — intervention group
Group type: EXPERIMENTAL
Intervention: FUdR
Number of subjects: 8
Study 2962925 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 8
Study 2962925 — intervention group
Group type: EXPERIMENTAL
Intervention: Aphidicolin
Number of subjects: 8
Study 2962925 — intervention group
Group type: COMPARATOR
Intervention: Caffeine and Aphidicolin
Number of subjects: 8
Study 30157103 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk supplementation (20 g of protein, 2 servings daily)
Number of subjects: 40
Study 30157103 — intervention group
Group type: COMPARATOR
Intervention: Native whey supplementation (20 g of protein, 2 servings daily)
Number of subjects: 40
Study 30157103 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (Milk and Native whey)
Number of subjects: 40
Study 29868868 — intervention group
Group type: EXPERIMENTAL
Intervention: Research‐Based and Developmentally Informed‐Parent home visiting program (REDI‐P)
Number of subjects: 200
Study 29868868 — intervention group
Group type: COMPARATOR
Intervention: math home learning games in the mail
Number of subjects: 200
Study 26919735 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART)
Number of subjects: 388
Study 25419179 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative glucose-insulin-potassium infusion (GIK)
Number of subjects: 315
Study 25419179 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative sliding-scale insulin boluses (BR)
Number of subjects: 315
Study 25419179 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 pre-treatment with liraglutide (LG)
Number of subjects: 315
Study 23015652 — intervention group
Group type: EXPERIMENTAL
Intervention: Orchidopexy at 9 months
Number of subjects: 213
Study 23015652 — intervention group
Group type: COMPARATOR
Intervention: Orchidopexy at 3 years
Number of subjects: 213
Study 23015652 — intervention group
Group type: EXPERIMENTAL
Intervention: Both ages (9 months and 3 years)
Number of subjects: 213
Study 23015652 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone levels (LH, FSH, testosterone, inhibin B)
Number of subjects: 213
Study 20568977 — intervention group
Group type: EXPERIMENTAL
Intervention: iodixanol 320 mgI/ml
Number of subjects: 100
Study 20568977 — intervention group
Group type: COMPARATOR
Intervention: iomeprol 400 mgI/ml
Number of subjects: 100
Study 18552710 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium lactis Bb12 (probiotic)
Number of subjects: 69
Study 15678547 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple sclerosis patients (MS)
Number of subjects: 76
Study 15678547 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 76
Study 11220429 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 10 mg
Number of subjects: 180
Study 11220429 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 5 mg
Number of subjects: 180
Study 11220429 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 2.5 mg
Number of subjects: 180
Study 11220429 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 180
Study 9431779 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional endoscopic sinus surgery (FESS)
Number of subjects: 40
Study 9431779 — intervention group
Group type: COMPARATOR
Intervention: Preoperative saccharin clearance times
Number of subjects: 40
Study 8495260 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily exercise regime of six exercises
Number of subjects: 44
Study 8495260 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercises)
Number of subjects: 44
Study 3812270 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive training (at least 85% of symptom‐limited exercise)
Number of subjects: 58
Study 3812270 — intervention group
Group type: COMPARATOR
Intervention: Moderate training (70 to 85% of symptom‐limited exercise)
Number of subjects: 58
Study 3812270 — intervention group
Group type: EXPERIMENTAL
Intervention: Both intensive and moderate training
Number of subjects: 58
Study 2567178 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine 40 micrograms kg‐1
Number of subjects: 26
Study 2567178 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine 10 or 20 micrograms kg‐1
Number of subjects: 26
Study 2567178 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine (various doses)
Number of subjects: 26
Study 31359765 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity walking (15 minutes)
Number of subjects: 112